{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:10:32Z","timestamp":1790680232339,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012541","name":"Herculesstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejmech.2022.114924","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T11:27:36Z","timestamp":1667993256000},"page":"114924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P1","title":["Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents"],"prefix":"10.1016","volume":"245","author":[{"given":"Charlotte","family":"Courtens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"van Charante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Quennesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Risseeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Coenye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-1264","authenticated-orcid":false,"given":"Serge","family":"Van Calenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114924_bib1","series-title":"World Malaria Report","author":"Who","year":"2021"},{"key":"10.1016\/j.ejmech.2022.114924_bib2","series-title":"Global Tuberculosis Report","author":"Who","year":"2021"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114924_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, No drugs: No ESKAPE! An update from the infectious diseases society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114924_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41426-018-0030-4","article-title":"Acinetobacter : an emerging pathogen with a versatile secretome","volume":"7","author":"Elhosseiny","year":"2018","journal-title":"Emerg. Microb. Infect."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114924_bib5","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1021\/acs.chemrev.6b00537","article-title":"The methylerythritol phosphate pathway to isoprenoids","volume":"117","author":"Frank","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.114924_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bioorg.2014.06.001","article-title":"Mechanism and inhibition of 1-Deoxy-d-Xylulose-5-Phosphate reductoisomerase","volume":"57","author":"Murkin","year":"2014","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114924_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jmb.2004.10.030","article-title":"The crystal structure of E. Coli 1-Deoxy-d-Xylulose-5-Phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation","volume":"345","author":"Mac Sweeney","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114924_bib8","doi-asserted-by":"crossref","unstructured":"Behrendt, C. T.; Kunfermann, A.; Illarionova, V.; Matheeussen, A.; Gr\u00e4wert, T.; Groll, M.; Rohdich, F.; Bacher, A.; Eisenreich, W.; Fischer, M.; et al. Synthesis and Antiplasmodial Activity of Highly Active Reverse Analogues of the Antimalarial Drug Candidate Fosmidomycin. ChemMedChem 5 (10), 1673\u20131676. https:\/\/doi.org\/10.1002\/cmdc.201000276.","DOI":"10.1002\/cmdc.201000276"},{"issue":"7","key":"10.1016\/j.ejmech.2022.114924_bib9","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.bmcl.2015.02.020","article-title":"Determination of the active stereoisomer of the MEP pathway-targeting antimalarial agent MMV008138, and initial structure\u2013activity studies","volume":"25","author":"Yao","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.ejmech.2022.114924_bib10","doi-asserted-by":"crossref","first-page":"9740","DOI":"10.1021\/jm5010978","article-title":"Development of inhibitors of the 2C-Methyl-d-Erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agents","volume":"57","author":"Masini","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114924_bib11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.21.2.224","article-title":"Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic","volume":"21","author":"Murakawa","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114924_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1475-2875-6-70","article-title":"Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria","volume":"6","author":"Na-Bangchang","year":"2007","journal-title":"Malar. J."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114924_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019334","article-title":"Fosmidomycin uptake into Plasmodium and babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways","volume":"6","author":"Baumeister","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114924_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/acsinfecdis.7b00176","article-title":"The methylerythritol phosphate pathway: promising drug targets in the fight against tuberculosis","volume":"4","author":"Wang","year":"2018","journal-title":"ACS Infect. Dis."},{"issue":"23","key":"10.1016\/j.ejmech.2022.114924_bib15","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1016\/j.bmcl.2011.09.123","article-title":"Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs","volume":"21","author":"Uh","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114924_bib16","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1021\/jm5019719","article-title":"Prodrugs of reverse fosmidomycin analogues","volume":"58","author":"Br\u00fccher","year":"2015","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114924_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ardp.200700069","article-title":"Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity","volume":"340","author":"Wiesner","year":"2007","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2022.114924_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2012.02.031","article-title":"Growth inhibition of Mycobacterium smegmatis by prodrugs of deoxyxylulose phosphate reducto-isomerase inhibitors, promising anti-mycobacterial agents","volume":"51","author":"Ponaire","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114924_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acsptsci.0c00076","article-title":"Metabolic efficacy of phosphate prodrugs and the remdesivir paradigm","volume":"3","author":"Wiemer","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114924_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/MMBR.00012-07","article-title":"Siderophore-based iron acquisition and pathogen control","volume":"71","author":"Miethke","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2022.114924_bib21","article-title":"A synthetic dual drug sideromycin induces gram-negative bacteria to commit suicide with a gram-positive antibiotic","author":"Liu","year":"2018","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114924_bib22","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/ja109665t","article-title":"Design, synthesis, and study of a Mycobactin\u2212Artemisinin conjugate that has selective and potent activity against tuberculosis and malaria","volume":"133","author":"Miller","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114924_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/acs.orglett.6b03671","article-title":"Key structural elements for cellular uptake of acinetobactin, a major siderophore of acinetobacter baumannii","volume":"19","author":"Song","year":"2017","journal-title":"Org. Lett."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114924_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/00397919408011298","article-title":"A simple preparation of chloromethyl esters of the blocked amino acids","volume":"24","author":"Harada","year":"1994","journal-title":"Synth. Commun."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114924_bib25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/00397918408075729","article-title":"Chlorosulfates as reagents in the synthesis of carboxylic acid esters under phase-transfer conditions","volume":"14","author":"Binderup","year":"1984","journal-title":"Synth. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114924_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tetlet.2006.10.160","article-title":"Overcoming steric effects in the coupling reaction of alkyloxycarbonyloxymethyl (AOCOM) halides with phenols: an efficient synthesis of AOCOM phenolic prodrugs","volume":"48","author":"Thomas","year":"2007","journal-title":"Tetrahedron Lett."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114924_bib27","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1021\/ol050543j","article-title":"Molybdenum oxides as highly effective dehydrative cyclization catalysts for the synthesis of oxazolines and thiazolines","volume":"7","author":"Sakakura","year":"2005","journal-title":"Org. Lett."},{"issue":"16","key":"10.1016\/j.ejmech.2022.114924_bib28","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/ol101346w","article-title":"Direct synthesis of oxazoles from aldehydes","volume":"12","author":"Graham","year":"2010","journal-title":"Org. Lett."},{"issue":"20","key":"10.1016\/j.ejmech.2022.114924_bib29","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1021\/jm4012559","article-title":"IspC as target for antiinfective drug discovery: synthesis, enantiomeric separation, and structural biology of fosmidomycin thia isosters","volume":"56","author":"Kunfermann","year":"2013","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2022.114924_bib30","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1021\/jm200694q","article-title":"Reverse fosmidomycin derivatives against the antimalarial drug target IspC (dxr)","volume":"54","author":"Behrendt","year":"2011","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2022.114924_bib31","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1021\/jm100211e","article-title":"Synthesis and evaluation of \u03b1-halogenated analogues of 3-(Acetylhydroxyamino)Propylphosphonic acid (FR900098) as antimalarials","volume":"53","author":"Verbrugghen","year":"2010","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114924_bib32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/acsinfecdis.6b00125","article-title":"Structure\u2013activity relationships of the MEPicides: N-acyl and O-linked analogs of FR900098 as inhibitors of dxr from Mycobacterium tuberculosis and Yersinia pestis","volume":"2","author":"San Jose","year":"2016","journal-title":"ACS Infect. Dis."},{"issue":"15","key":"10.1016\/j.ejmech.2022.114924_bib33","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1016\/j.bmc.2006.04.018","article-title":"Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of fosmidomycin and FR900098","volume":"14","author":"Kurz","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114924_bib34","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ejmech.2006.06.015","article-title":"Arylmethyl substituted derivatives of fosmidomycin: synthesis and antimalarial activity","volume":"41","author":"Schl\u00fcter","year":"2006","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114924_bib35","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.bmcl.2015.03.077","article-title":"Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues","volume":"25","author":"Fa\u00edsca Phillips","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.ejmech.2022.114924_bib36","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1021\/bi0206107","article-title":"Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure","volume":"42","author":"Castilho","year":"2003","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.ejmech.2022.114924_bib37","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1021\/jo101873v","article-title":"CAN-mediated oxidations for the synthesis of xanthones and related products","volume":"75","author":"Johnson","year":"2010","journal-title":"J. Org. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2022.114924_bib38","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1016\/j.bmc.2006.05.007","article-title":"Synthesis and anticancer evaluation of bis(benzimidazoles), bis(benzoxazoles), and benzothiazoles","volume":"14","author":"Huanga","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114924_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/anie.200352154","article-title":"A short, atom-economical entry to tetrahydroxanthenones","volume":"43","author":"Lesch","year":"2004","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422008261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422008261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:48:11Z","timestamp":1759330091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422008261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":39,"alternative-id":["S0223523422008261"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114924","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114924"}}